ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,291.68
0.36%
Dow Jones
44,736.57
0.99%
Gold vs US Dollar
2,610.69
-3.85%
Brent Oil
72.605
0.00%
Bitcoin
93,323.62
0.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) News

Bio Path (BPTH)

Bio Path Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPTH
DateTimeSourceHeadlineSymbolCompany
25/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/11/202412:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
13/11/202416:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
08/11/202412:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024NASDAQ:BPTHBio Path Holdings Inc
06/11/202421:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BPTHBio Path Holdings Inc
28/10/202420:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BPTHBio Path Holdings Inc
28/10/202420:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
28/10/202420:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
23/10/202411:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
23/10/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
22/10/202419:11Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BPTHBio Path Holdings Inc
18/10/202421:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
17/10/202420:37Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
10/10/202421:24GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
09/10/202400:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
08/10/202411:00GlobeNewswire Inc.Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of ObesityNASDAQ:BPTHBio Path Holdings Inc
16/09/202411:00GlobeNewswire Inc.Bio-Path Holdings Announces Publication in BiomedicinesNASDAQ:BPTHBio Path Holdings Inc
13/09/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
03/09/202411:00GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
21/08/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
21/08/202411:00GlobeNewswire Inc.Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid TumorsNASDAQ:BPTHBio Path Holdings Inc
15/08/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/08/202411:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/08/202420:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/08/202411:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
08/08/202411:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
01/08/202422:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
01/08/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
01/08/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Your Recent History

LSE
KGF
Kingfisher
LSE
GSF
Gore Street Energy Storage
LSE
UPS
LSE
VAST
Vast Resources
LSE
SRSP
Sirius Petroleum
LSE
LGEN
Legal & General
LSE
SMIN
Smiths
LSE
TW.
Taylor Wimpey
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 65%* for Gold Trader

    1 year 40%, 2 years 50% and *3 years 65%

    *Across 3 years £3655.44 only £1279.40